GOCO vs. FANH, RDZN, EHTH, ZBAO, SLQT, COFS, NPV, OXSQ, BHR, and BPRN
Should you be buying GoHealth stock or one of its competitors? The main competitors of GoHealth include Fanhua (FANH), Roadzen (RDZN), eHealth (EHTH), Zhibao Technology (ZBAO), SelectQuote (SLQT), ChoiceOne Financial Services (COFS), Nuveen Virginia Quality Municipal Income Fund (NPV), Oxford Square Capital (OXSQ), Braemar Hotels & Resorts (BHR), and Princeton Bancorp (BPRN). These companies are all part of the "finance" sector.
Fanhua (NASDAQ:FANH) and GoHealth (NASDAQ:GOCO) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, media sentiment, risk, valuation, community ranking, dividends and earnings.
Fanhua has a net margin of 8.67% compared to Fanhua's net margin of -8.59%. GoHealth's return on equity of 12.11% beat Fanhua's return on equity.
26.7% of Fanhua shares are held by institutional investors. Comparatively, 24.2% of GoHealth shares are held by institutional investors. 25.6% of Fanhua shares are held by company insiders. Comparatively, 35.0% of GoHealth shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Fanhua received 194 more outperform votes than GoHealth when rated by MarketBeat users. Likewise, 54.31% of users gave Fanhua an outperform vote while only 53.42% of users gave GoHealth an outperform vote.
Fanhua has higher earnings, but lower revenue than GoHealth. GoHealth is trading at a lower price-to-earnings ratio than Fanhua, indicating that it is currently the more affordable of the two stocks.
In the previous week, Fanhua had 1 more articles in the media than GoHealth. MarketBeat recorded 1 mentions for Fanhua and 0 mentions for GoHealth. GoHealth's average media sentiment score of 0.25 beat Fanhua's score of 0.00 indicating that Fanhua is being referred to more favorably in the media.
GoHealth has a consensus target price of $13.00, suggesting a potential upside of 46.89%. Given Fanhua's higher possible upside, analysts plainly believe GoHealth is more favorable than Fanhua.
Summary
Fanhua beats GoHealth on 12 of the 15 factors compared between the two stocks.
Get GoHealth News Delivered to You Automatically
Sign up to receive the latest news and ratings for GOCO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding GOCO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
GoHealth Competitors List
Related Companies and Tools
